---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-26-000004"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:39:21.521243+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q2 revenue $65.6B (+19%), non-GAAP EPS $2.63 (+36%), raises FY26 EPS outlook to $10.15-$10.35

## Summary
- Revenue $65.6B (+19% YoY); GAAP diluted EPS $1.97 (+19%); non-GAAP diluted EPS $2.63 (+36%).
- Pharma & Specialty profit $687M (+29%); Global Medical Products profit $37M (+106%); Other profit $179M (+52%).
- FY2026 non-GAAP EPS guidance raised to $10.15-$10.35, representing 23%-26% growth.
- Year-to-date share repurchases of $750M completed; reached targeted leverage range.
- Acquired Solaris Health (urology MSO, >750 providers) on Nov 3; introduced ContinuCare Pathway program.

## SEC filing metadata
- accession: 0000721371-26-000004
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137126000004/0000721371-26-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137126000004/cah-20260205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-26-000004
- JSON: https://secwatch.observer/filing/0000721371-26-000004.json
- Plain text: https://secwatch.observer/filing/0000721371-26-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.